During the past decade, Sankikai Yokohama Shin midori General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sankikai Yokohama Shin midori General Hospital" are "Nocturia" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Sankikai Yokohama Shin midori General Hospital" in a lesser frequency.

Most popular intervention types in "Sankikai Yokohama Shin midori General Hospital" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "A. Desmopressin 10 microgram" (1 trials), "A: Desmopressin 25 µg" (1 trials), "B. Desmopressin 50 µg" (1 trials) and "B: Desmopressin 25 microgram" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sankikai Yokohama Shin midori General Hospital" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sankikai Yokohama Shin midori General Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sankikai Yokohama Shin midori General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sankikai Yokohama Shin midori General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".